跳至主要内容
临床试验/NCT01745172
NCT01745172已完成不适用

Carotid Body Removal for the Treatment of Chronic Diseases Characterized by Excessive Central Sympathetic Activity Including Resistant Hypertension: a Pilot Study.

Noblewell2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2013年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4
试验地点
2
主要终点
Change of Blood Pressure

研究概览

简要总结

This is a pilot study to assess the effectiveness, safety and feasibility of carotid body removal in patients with high blood pressure (hypertension) resistant to medical treatment. Patients with high blood pressure are at significant risk of medical complications including stroke and heart disease. The principle research question is whether removal of the carotid body will lead to an improvement in the blood pressure of this patient group.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of participants will be 18-75 years
  • Resistant HTN criteria:
  • Daytime mean ambulatory systolic blood pressure ≥135mmHg and office systolic blood pressure ≥150mmHg
  • Patients on at least three anti-hypertensive medications, including a diuretic, at maximum tolerated dose
  • No evidence of causes for secondary HTN following thorough clinical assessment
  • Patient medication concordance will be monitored via medication/blood pressure diary

排除标准

  • Calculated GFR <45ml/min/1.73m2
  • Carotid body located outside the defined carotid septum
  • Obstructive carotid atherosclerotic disease with >50% stenosis
  • Oxygen desaturation at rest below 92%
  • Known structural lung disease
  • Requirement for oxygen therapy to maintain oxygen saturation
  • Patients wish to participate in mountain climbing, skin diving or free diving
  • Pregnancy or anticipation of pregnancy
  • Palliative care/chemotherapy
  • Acute coronary syndrome or unstable angina
  • Stroke or transient ischaemic attack (TIA) < 6 months prior to procedure
  • Expected life expectancy less than 12 months due to other disease
  • Intravenous drug use
  • Alcohol intake >28 units/week
  • Febrile illness within two weeks of participation
  • Unable to attend for follow up appointments in Bristol at 1, 3, 6, 12 and 24 months post-operatively.
  • MR imaging related exclusion criteria (all participants):
  • Pace-maker, implantable cardiac defibrillator, cerebral metallic clips or other implanted metal devices/structures
  • Unable to tolerate scanner or history of panic attacks/claustrophobia
  • Learning disability, significant hearing or visual impairment (participant would need to able to communicate from within the MRI scanner)

结局指标

主要结局

Change of Blood Pressure

时间窗: Baseline and 3 months

Change from Baseline Blood Pressure at 3 months

次要结局

未报告次要终点

研究者

发起方
Noblewell
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Carotid Body Removal for the Treatment of Resistant... | 临床试验